| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
45,057 |
41,853 |
$4.20M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
30,106 |
26,759 |
$1.94M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
15,278 |
14,483 |
$1.31M |
| 80053 |
Comprehensive metabolic panel |
20,071 |
16,219 |
$1.05M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,550 |
7,548 |
$1.02M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
6,212 |
1,527 |
$587K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,113 |
2,729 |
$576K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,255 |
3,758 |
$536K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
4,834 |
1,390 |
$494K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,215 |
1,247 |
$436K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,137 |
3,017 |
$375K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
14,714 |
11,452 |
$358K |
| 87275 |
|
23,385 |
22,015 |
$219K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,750 |
1,489 |
$203K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,288 |
2,098 |
$171K |
| G0378 |
Hospital observation service, per hour |
16,053 |
6,915 |
$159K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
806 |
712 |
$159K |
| 87070 |
|
10,469 |
9,874 |
$154K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
17,448 |
16,701 |
$126K |
| 87088 |
|
10,572 |
9,724 |
$85K |
| 93975 |
|
3,773 |
3,188 |
$83K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,310 |
1,956 |
$76K |
| 71046 |
Radiologic examination, chest; 2 views |
11,072 |
10,378 |
$70K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,519 |
1,357 |
$66K |
| 85027 |
|
39,845 |
29,740 |
$64K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
470 |
426 |
$62K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
433 |
404 |
$61K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
1,194 |
983 |
$55K |
| 81001 |
|
17,096 |
15,294 |
$53K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,219 |
1,071 |
$50K |
| 80047 |
|
1,914 |
1,502 |
$48K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
645 |
554 |
$47K |
| 76830 |
Ultrasound, transvaginal |
784 |
704 |
$45K |
| 76775 |
|
616 |
589 |
$45K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
708 |
629 |
$41K |
| 81003 |
|
9,225 |
8,397 |
$39K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
747 |
621 |
$39K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,033 |
1,940 |
$37K |
| 36415 |
Collection of venous blood by venipuncture |
1,596 |
1,367 |
$37K |
| 74018 |
|
2,737 |
2,561 |
$36K |
| A9270 |
Non-covered item or service |
5,807 |
1,105 |
$35K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,152 |
3,362 |
$35K |
| 84702 |
|
3,540 |
2,830 |
$25K |
| 81025 |
|
12,647 |
11,368 |
$25K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
219 |
205 |
$23K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,365 |
2,914 |
$23K |
| 86850 |
|
3,200 |
2,722 |
$22K |
| 71045 |
Radiologic examination, chest; single view |
7,564 |
6,362 |
$22K |
| 12011 |
|
270 |
255 |
$20K |
| 97163 |
|
434 |
369 |
$19K |
| 80076 |
|
6,651 |
6,094 |
$17K |
| 74019 |
|
1,280 |
1,227 |
$17K |
| 87807 |
|
8,138 |
7,661 |
$16K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,168 |
1,054 |
$15K |
| 87077 |
|
1,843 |
1,663 |
$15K |
| 73610 |
|
870 |
783 |
$14K |
| 73070 |
|
538 |
481 |
$14K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
191 |
188 |
$14K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14,759 |
12,717 |
$13K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,464 |
1,240 |
$12K |
| 85610 |
|
7,719 |
6,354 |
$12K |
| S0028 |
Injection, famotidine, 20 mg |
1,455 |
1,101 |
$12K |
| 85730 |
|
7,644 |
6,261 |
$12K |
| 73562 |
|
845 |
737 |
$12K |
| S5010 |
5% dextrose and 0.45% normal saline, 1000 ml |
14 |
13 |
$9K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,068 |
826 |
$9K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,141 |
8,085 |
$9K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,168 |
3,914 |
$9K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
955 |
769 |
$8K |
| 73630 |
|
795 |
727 |
$8K |
| 86140 |
|
7,065 |
6,175 |
$8K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,760 |
3,981 |
$8K |
| 70491 |
|
32 |
27 |
$8K |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,583 |
639 |
$7K |
| 84484 |
|
6,842 |
4,755 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
11,844 |
11,234 |
$7K |
| 87045 |
|
269 |
247 |
$7K |
| 73110 |
|
462 |
424 |
$7K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,639 |
4,053 |
$7K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,308 |
865 |
$7K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,144 |
860 |
$6K |
| J2704 |
Injection, propofol, 10 mg |
1,427 |
898 |
$6K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
11,154 |
8,768 |
$6K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
190 |
150 |
$6K |
| 87040 |
|
6,882 |
6,015 |
$6K |
| 74240 |
|
102 |
99 |
$5K |
| 83735 |
|
2,211 |
1,754 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,559 |
4,068 |
$5K |
| 86900 |
|
3,672 |
3,120 |
$5K |
| 73130 |
|
547 |
494 |
$5K |
| J3490 |
Unclassified drugs |
476 |
360 |
$5K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
152 |
136 |
$4K |
| 93971 |
|
310 |
263 |
$4K |
| 96368 |
|
45 |
44 |
$4K |
| 01922 |
|
50 |
47 |
$4K |
| 73030 |
|
315 |
274 |
$4K |
| 86901 |
|
4,855 |
4,107 |
$4K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
6,868 |
6,518 |
$4K |
| 76870 |
|
24 |
24 |
$3K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
334 |
246 |
$3K |
| 12001 |
|
56 |
49 |
$3K |
| 72100 |
|
148 |
119 |
$3K |
| 76801 |
|
710 |
611 |
$3K |
| 76857 |
|
944 |
888 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
18 |
13 |
$2K |
| 83880 |
|
1,455 |
1,204 |
$2K |
| 86780 |
|
65 |
54 |
$2K |
| 87276 |
|
23,379 |
22,008 |
$2K |
| 82550 |
|
1,545 |
1,238 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,141 |
2,058 |
$2K |
| 82272 |
|
47 |
41 |
$2K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
33 |
25 |
$2K |
| 73090 |
|
204 |
184 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,161 |
1,740 |
$2K |
| 70486 |
|
16 |
15 |
$2K |
| 92523 |
|
13 |
12 |
$2K |
| 74241 |
|
18 |
16 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,048 |
4,229 |
$1K |
| 72131 |
|
63 |
51 |
$1K |
| 83690 |
|
7,833 |
6,761 |
$1K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
75 |
75 |
$1K |
| 29125 |
|
55 |
48 |
$985.74 |
| C1769 |
Guide wire |
55 |
37 |
$943.94 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,420 |
1,205 |
$900.98 |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,155 |
1,031 |
$874.02 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,612 |
2,379 |
$871.92 |
| 82247 |
|
493 |
373 |
$840.26 |
| 84703 |
|
471 |
413 |
$813.91 |
| 87210 |
|
43 |
39 |
$731.89 |
| 84112 |
|
90 |
81 |
$723.80 |
| 83605 |
|
2,847 |
2,205 |
$690.11 |
| 82040 |
|
397 |
308 |
$687.79 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
208 |
195 |
$679.41 |
| 88342 |
|
320 |
267 |
$666.20 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
125 |
98 |
$616.49 |
| 73590 |
|
73 |
59 |
$533.02 |
| 85379 |
|
867 |
729 |
$488.32 |
| 84450 |
|
396 |
310 |
$402.41 |
| 84460 |
|
396 |
310 |
$402.41 |
| 84155 |
|
396 |
310 |
$402.41 |
| 84075 |
|
396 |
310 |
$402.41 |
| 85014 |
|
18 |
12 |
$346.86 |
| 00813 |
|
31 |
24 |
$339.12 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
254 |
222 |
$338.58 |
| 73140 |
|
17 |
13 |
$277.02 |
| 88304 |
|
627 |
549 |
$257.22 |
| 82728 |
|
216 |
174 |
$227.77 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,782 |
1,070 |
$190.29 |
| 82570 |
|
13 |
13 |
$176.43 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
972 |
861 |
$175.10 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
208 |
195 |
$171.19 |
| 84550 |
|
311 |
265 |
$129.03 |
| 70210 |
|
41 |
39 |
$118.41 |
| 82248 |
|
1,979 |
1,386 |
$88.66 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
29 |
25 |
$65.66 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
278 |
227 |
$65.16 |
| 87205 |
|
600 |
488 |
$64.47 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
38 |
37 |
$60.91 |
| 86308 |
|
158 |
151 |
$57.53 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
132 |
84 |
$54.45 |
| 80061 |
Lipid panel |
149 |
130 |
$48.48 |
| 86738 |
|
178 |
166 |
$45.28 |
| 85652 |
|
1,802 |
1,644 |
$39.82 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
221 |
216 |
$16.67 |
| J1815 |
Injection, insulin, per 5 units |
368 |
156 |
$15.43 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
86 |
66 |
$15.08 |
| 86920 |
|
27 |
24 |
$9.12 |
| 84439 |
|
89 |
83 |
$7.68 |
| 96376 |
|
53 |
43 |
$5.06 |
| 80320 |
|
60 |
53 |
$4.89 |
| 87186 |
|
148 |
130 |
$3.97 |
| 87075 |
|
47 |
40 |
$1.84 |
| 82150 |
|
97 |
87 |
$1.77 |
| 00840 |
|
148 |
134 |
$1.56 |
| 84100 |
|
259 |
223 |
$1.56 |
| 00731 |
|
30 |
27 |
$1.17 |
| 72040 |
|
31 |
24 |
$0.92 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
27 |
24 |
$0.46 |
| 86923 |
|
47 |
44 |
$0.00 |
| 83540 |
|
66 |
55 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
86 |
51 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
330 |
192 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
64 |
48 |
$0.00 |
| 85045 |
|
169 |
124 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
85 |
76 |
$0.00 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
64 |
26 |
$0.00 |
| 86665 |
|
13 |
12 |
$0.00 |
| 86663 |
|
13 |
12 |
$0.00 |
| 85384 |
|
20 |
15 |
$0.00 |
| 82009 |
|
12 |
12 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
17 |
14 |
$0.00 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
32 |
31 |
$0.00 |
| 97116 |
|
22 |
12 |
$0.00 |
| 41899 |
Unlisted procedure, dentoalveolar structures |
33 |
32 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
26 |
12 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
32 |
25 |
$0.00 |
| 82077 |
|
72 |
63 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
103 |
66 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
15 |
15 |
$0.00 |
| 84157 |
|
45 |
40 |
$0.00 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
33 |
33 |
$0.00 |
| 85018 |
|
14 |
12 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
13 |
12 |
$0.00 |
| 86664 |
|
13 |
12 |
$0.00 |
| 83615 |
|
19 |
13 |
$0.00 |
| 73502 |
|
20 |
13 |
$0.00 |